期刊
VACCINES
卷 9, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/vaccines9010001
关键词
oral vaccination; subunit vaccines; mucosal immunity; secretory IgA; adjuvants; targeted delivery; Micro; and nanoparticles
资金
- concerted research action (GOA) from Ghent University [BOF15/GOA/031]
- research Foundation Flanders (FWO-Vlaanderen)
Oral vaccines are crucial for gut immunity, but face challenges due to the unique environment of the gastrointestinal tract, requiring strategies to overcome barriers and induce robust immune responses.
Many pathogens invade the host at the intestinal surface. To protect against these enteropathogens, the induction of intestinal secretory IgA (SIgA) responses is paramount. While systemic vaccination provides strong systemic immune responses, oral vaccination is the most efficient way to trigger protective SIgA responses. However, the development of oral vaccines, especially oral subunit vaccines, is challenging due to mechanisms inherent to the gut. Oral vaccines need to survive the harsh environment in the gastrointestinal tract, characterized by low pH and intestinal proteases and need to reach the gut-associated lymphoid tissues, which are protected by chemical and physical barriers that prevent efficient uptake. Furthermore, they need to surmount default tolerogenic responses present in the gut, resulting in suppression of immunity or tolerance. Several strategies have been developed to tackle these hurdles, such as delivery systems that protect vaccine antigens from degradation, strong mucosal adjuvants that induce robust immune responses and targeting approaches that aim to selectively deliver vaccine antigens towards specific immune cell populations. In this review, we discuss recent advances in oral vaccine design to enable the induction of robust gut immunity and highlight that the development of next generation oral subunit vaccines will require approaches that combines these solutions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据